Healthcare trends

The rising prevalence of angina and coronary heart diseases, growing healthcare expenditure, and increasing geriatric and obese population are expected to drive the global angina market, during the forecast period. However, low per capita healthcare expenditure and high cost for therapeutic procedures such as coronary bypass surgery restraints the market growth. The Market Key Players are: · Anthera (U.S.), · Taxus Cardium (U.S.), · Astellas Pharma (Japan), · Sanofi (France), · Bayer AG (Germany), · Merck & Co., Inc. (U.S.), · Torrent Pharmaceuticals Limited (India), · Huya Bioscience International (U.S.), · Viromed Co. Ltd. (South Korea), · Baxter (U.S.), Angina Market  is expected to grow at an approximate CAGR of 5.1% during the forecast period  S egmentation The global angina market is segmented on the basis of type, diagnosis, treatment, and end-user. · On the basis of type, the market is segmented into angina pectoris, unstable a...

Angina Market is expected to grow at an approximate CAGR of 5.1% during the forecast period The rising prevalence of angina and coronary heart diseases, growing healthcare expenditure, and increasing geriatric and obese population are expected to drive the global angina market, during the forecast period. However, low per capita healthcare expenditure and high cost for therapeutic procedures such as coronary bypass surgery restraints the market growth. The Market Key Players are: ·          Anthera (U.S.), ·          Taxus Cardium (U.S.), ·          Astellas Pharma (Japan), ·          Sanofi (France), ·          Bayer AG (Germany), ·          Merck & Co., Inc. (U.S.), ·          T...